Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy

Annali dell'Istituto Superiore di Sanita

Volumn 46, Issue 1, 2010, Pages 59-65

  Camoni, Laura ^a   Regine, Vincenza ^a   Salfa, Maria Cristina ^a   Nicoletti, Giovanni ^b   Canuzzi, Pietro ^b   Magliocchetti, Natalia ^b   Rezza, Giovanni ^a   Suligoi, Barbara ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Ministero del Lavoro della Salute e delle Politiche Sociali   (Italy)

Author keywords

Drug users; Hepatitis B; Hepatitis C; HIV

Indexed keywords

ADDICTION; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MALE; PREVALENCE; SUBSTANCE ABUSE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; ITALY; MALE; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 77949802550     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0021-25712010000100008     Document Type: Article

References (15)

1. Centro Operativo AIDS (COA). Aggiornamento dei casi di AIDS notificati in Italia al 31 dicembre 2005. Not Ist Super Sanità 2006;19(Suppl. 1). Available from: http://www.iss.it/binary/publ/cont/0394-9303-2006-I-19-06. 1153308414.pdf; last visited 20/7/09.
2. Mele A, Tosti ME, Spada E, et al. Epidemiology of acute viral hepatitis: twenty years of surveillance through SEIEVA in Italy and a review of the literature. Roma: Istituto Superiore di Sanità; 2006 (Rapporti ISTISAN, 06/12). Available from: http://www.iss.it/publ/rapp/cont.php?id=1963&lang= 1&tipo=5&anno=2006; last visited 20/7/09
3. Ministero della Salute. Sistema Informativo Sanitario - dipartimento per la Prevenzione. Rilevazione attività nel settore delle tossicodipendenze, anno 2005. Roma: Ministero della Salute; 2006. Available from: http://www.ministerosalute.it/imgs/C-17-pubblicazioni-542-allegato.pdf; last visited 20/7/09.
4. EuroHIV. HIV/AIDS Surveillance in Europe 2003. EuroHIV 2004;70:59-73. Paris: EuroHIV; 2004. Available from: www.eurohiv.org/reports/report-70/pdf/ report-eurohiv-70.pdf; last visited 20/7/09.
5. Lindenburg CE, Krol A, Smit C, et al. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study. AIDS 2006;20:1771-1775
6. Des Jarlais DC, Arasteh K, Perlis T, et al. The transition from injection to non-injection drug use: long term outcomes among heroin and cocaine users in New York City. Addiction 2007;102:778-785
7. Giuliani M, Suligoi B and the Italian Surveillance Working Group. Differences between nonnational and indigenous patients with sexually transmitted infections in Italy and insight into the control of sexually transmitted infections. Sex Transm Dis 2004;31:79-84.
8. Estebanez PE, Russel NK, Aguilar D, Beland F, Zunzunegui MV. Women, drugs and HIV/AIDS: results of a multicentre European study. Int J Epidemiol 2000;29:734-743
9. Rezza G, Salmaso S, Abeni D, et al. HIV prevalence and frequency of risk behavior in injecting drug users entering treatment and out of treatment: a cross-sectional study in five Italian cities. J Drug Issues 1994;24:527-535
10. March JC, Oviedo-Joekes E, Romero M. Factors associated with reported hepatitis C and HIV among injecting drug users in ten European cities. Enferm Infec Microbiol Clin 2007;25:91-97
11. Quaglio G, Lugoboni F, Mezzelani P, Des Jarlais DC, Lechi A. Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients. BMC Public Health 2006;6:216.
12. European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2005: the state of the drug problem in Europe. Lisbon: EMCDDA; 2006.
13. Amesty S, Ompad DC, Galea, et al. Prevalence and correlates of previous hepatitis B vaccination and infection among young drug-users in New York City. J Community Health 2008;33(3):139-148
14. Crofts N, Aitken CK. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Med J Aust 1997;167:17-20.
15. Neaigus A, Gyarmathy VA, Miller M, Fiedman SR, Des Jarlais DC. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. J Infect Dis 2007;195:1052-1061